Prevalence and associated factors of opioid-related disorders among patients with chronic pain: a single-center retrospective study in a Chinese tertiary hospital

BACKGROUND: Opioid-related disorders (ORD) among patients with chronic pain represents a significant clinical challenge, yet surveillance data within Chinese healthcare settings remain limited. This study explored the feasibility of utilizing hospital information system (HIS) data to quantify indicators of ORD and analyze associated factors in a tertiary care setting. METHODS: A retrospective study was conducted at Nanjing Drum Tower Hospital. Patients with chronic pain prescribed opioids for ≥ 90 days between 2022 and 2023 were included. Indicators of ORD were defined by the presence of an ICD-10 diagnosis of opioid use disorder (OUD), documented subjective symptoms, or prescription overlap accounting for ≥ 25% of the total treatment duration. Multivariate logistic regression was performed to identify independent associated factors for ORD. RESULTS: Among 751 eligible patients, 126 (16.8%) met the criteria for ORD. Multivariate analysis revealed that a history of cancer (OR: 2.47; 95% CI: 1.26-4.86), obtaining prescriptions from multiple departments (OR: 1.41; 95% CI: 1.16-1.71), and the initial use of sustained-release (SR) formulations (OR: 1.97; 95% CI: 1.18-3.29) were significant independent associated factors. Furthermore, every 50 mg increment in the maximum daily morphine milligram equivalent (MME) was significantly associated with an increased factor of ORD (OR: 1.27; 95% CI: 1.18-1.37). CONCLUSION: Iatrogenic ORD is a notable concern in this population, driven by specific prescribing patterns such as the early initiation of SR formulations and multi-source prescribing. These findings highlight the urgency of implementing active HIS-based surveillance algorithms and establishing regional inter-hospital data sharing to mitigate the risks of long-term dependency and OUD.

Authors

Institutions

Publication Details

Journal
BMC Anesthesiology
Published
2026-05-27
DOI
https://doi.org/10.1186/s12871-026-03941-6
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and associated factors of opioid-related disorders among patients with chronic pain: a single-center retrospective study in a Chinese tertiary hospital

董印玲, Xiaoyan Wu, Hang Zhang, Zhiyan Xu et al.
BMC Anesthesiology
Opioid Use Disorder Treatment
article

Prevalence and associated factors of opioid-related disorders among patients with chronic pain: a single-center retrospective study in a Chinese tertiary hospital

董印玲, Xiaoyan Wu, Hang Zhang, Zhiyan Xu, Jinyuan Zhang, Weihong Ge, Cheng Si
article en

Abstract

BACKGROUND: Opioid-related disorders (ORD) among patients with chronic pain represents a significant clinical challenge, yet surveillance data within Chinese healthcare settings remain limited. This study explored the feasibility of utilizing hospital information system (HIS) data to quantify indicators of ORD and analyze associated factors in a tertiary care setting. METHODS: A retrospective study was conducted at Nanjing Drum Tower Hospital. Patients with chronic pain prescribed opioids for ≥ 90 days between 2022 and 2023 were included. Indicators of ORD were defined by the presence of an ICD-10 diagnosis of opioid use disorder (OUD), documented subjective symptoms, or prescription overlap accounting for ≥ 25% of the total treatment duration. Multivariate logistic regression was performed to identify independent associated factors for ORD. RESULTS: Among 751 eligible patients, 126 (16.8%) met the criteria for ORD. Multivariate analysis revealed that a history of cancer (OR: 2.47; 95% CI: 1.26-4.86), obtaining prescriptions from multiple departments (OR: 1.41; 95% CI: 1.16-1.71), and the initial use of sustained-release (SR) formulations (OR: 1.97; 95% CI: 1.18-3.29) were significant independent associated factors. Furthermore, every 50 mg increment in the maximum daily morphine milligram equivalent (MME) was significantly associated with an increased factor of ORD (OR: 1.27; 95% CI: 1.18-1.37). CONCLUSION: Iatrogenic ORD is a notable concern in this population, driven by specific prescribing patterns such as the early initiation of SR formulations and multi-source prescribing. These findings highlight the urgency of implementing active HIS-based surveillance algorithms and establishing regional inter-hospital data sharing to mitigate the risks of long-term dependency and OUD.

BMC Anesthesiology
Nanjing University of Chinese Medicine (CN), Nanjing Drum Tower Hospital (CN)
Wu Jieping Medical Foundation
Good health and well-being
Openalex Percentile: Top 6%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.